Stacy Feld had settled into a satisfying career in biotech business development when she accidentally found her way into a meeting with Genentech’s CEO and a tiny startup company called 23andMe. The moment sparked a sudden realization that the best [See the full post…]

When 23andMe veteran Linda Avey pitched her new startup, We Are Curious (which focuses on integrating patient-reported symptoms and experiences) she thought she’d emphasize a condition that seemed like an easy win: menopause-associated symptoms. VCs, she reasoned, would be immediately [See the full post…]